← Back to All Filings

Viatris Director Reports RSU Vesting and Managed Account Activity

Low SignificanceMarch 10, 2026 at 7:18:13 PM EDT

Viatris Inc

$VTRS4CIK: 0001792044

Subscribe to track VTRS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Viatris Director Reports RSU Vesting and Managed Account Activity

Company: Viatris Inc (VTRS) Form: 4 | Filed: 2026-03-10 Significance: Low

Insider: SIMMONS DAVID S Title: Director | Relationship: Director

Transaction (Primary): • Type: Exercise/Vesting (M) • Shares: 22,820 • Price: $0.00 • Value: $0 (Compensation Vesting) • Owned After: 23,344

Key Insight: Routine vesting of Restricted Stock Units (RSUs) and a new grant. Filing also reports small, automated purchases from 2025 via managed accounts.

Market Context: Transaction is negligible relative to $17.19B market cap. No directional signal.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Viatris Inc (VTRS)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Routine compensation vesting and disclosure of small, automated historical purchases.
  • Market Impact: Neutral - The activity is non-discretionary and immaterial relative to market capitalization.

Company Information

FieldValue
CompanyViatris Inc
Ticker SymbolVTRS
CIK0001792044
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameSIMMONS DAVID S
CIK0001508519
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2026-03-06
Transaction CodeM (Exercise/Vesting)
Security TypeCommon Stock
Shares Involved22,820
Price Per Share$0.00
Total Value$0 (Compensation)
Shares Owned After23,344
Ownership TypeDirect

Note: Filing also includes a new grant of 15,890 RSUs and small historical purchases (499 shares total) made in 2025 via managed accounts.

Financial Impact Assessment

Transaction Materiality

MetricValue
Market Cap$17.19 Billion
Shares Outstanding1,151,390,000
Transaction Value (Est. Market)~$237,000 (at ~$10.42/share)
% of Market Cap~0.0014%
Shares Transacted22,820
% of Shares Outstanding~0.002%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: Viatris is a Large Cap company ($17.19B). A transaction of this size is statistically irrelevant to the stock price.
  • Ownership Concentration: The insider holds ~23,344 shares directly, which represents a negligible percentage (<0.01%) of the 1.15 billion shares outstanding.
  • Dilution Impact: The vesting of ~23,000 shares and new grant of ~16,000 shares creates virtually zero dilution (0.003% of float).

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The primary activity is the scheduled vesting of compensation (RSUs). The "Purchases" listed (Code P) occurred in 2025 and were executed by investment advisors in managed accounts (Footnote 1), indicating they were not discretionary decisions by the insider based on current material information.

Volume & Sentiment

  • Expected Volume Impact: None.
  • Sentiment Indicator: Neutral. The filing is administrative in nature.

Additional Context

Transaction Notes

  • Managed Accounts: Footnote 1 clarifies that the small purchases (286 and 213 shares) were part of an investment advisor's strategy to mirror index funds, not active trading by Mr. Simmons.
  • Compensation: The filing reflects the annual vesting cycle (March 6) for directors/officers and the grant of new incentives vesting in 2027.
Topics:#VTRS#Viatris#SECFiling#InsiderTrading#PharmaStocks#Form4#StockMarket#FinancialEducation

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.